{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T20:03:56Z","timestamp":1785009836170,"version":"3.55.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.rbmo.2025.105206","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T23:25:26Z","timestamp":1754954726000},"page":"105206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Network meta-analysis of progestogen administration routes for luteal phase support in fresh embryo transfer IVF cycles"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0606-5804","authenticated-orcid":false,"given":"Georg","family":"Griesinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Labarta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somjate","family":"Manipalviratn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kshitiz","family":"Murdia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Pabuccu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Kahler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3-4","key":"10.1016\/j.rbmo.2025.105206_bib0001","first-page":"203","article-title":"Intramuscular versus vaginal administration of progesterone for luteal phase support after in vitro fertilization and embryo transfer. A comparative randomized study","volume":"26","author":"Abate","year":"1999","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.rbmo.2025.105206_bib0002","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF03349699","article-title":"A comparative, randomized study of three different progesterone support of the luteal phase following IVF\/ET program","volume":"18","author":"Artini","year":"1995","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"10.1016\/j.rbmo.2025.105206_bib0003","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1093\/humrep\/deu194","article-title":"A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization","volume":"29","author":"Baker","year":"2014","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.rbmo.2025.105206_bib0004","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.fertnstert.2014.03.026","article-title":"Live birth is the correct outcome for clinical trials evaluating therapy for the infertile couple","volume":"101","author":"Barnhart","year":"2014","journal-title":"Fertil Steril"},{"issue":"9","key":"10.1016\/j.rbmo.2025.105206_bib0005","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1210\/jc.2002-021953","volume":"88","author":"Beckers","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.rbmo.2025.105206_bib0006","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/oxfordjournals.humrep.a136511","article-title":"The effect of dydrogesterone supplementation in an IVF programme","volume":"2","author":"Belaisch-Allart","year":"1987","journal-title":"Hum Reprod"},{"issue":"12","key":"10.1016\/j.rbmo.2025.105206_bib0007","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1093\/humrep\/des341","article-title":"A prospective randomized multicentre study comparing vaginal progesterone gel and vaginal micronized progesterone tablets for luteal support after in vitro fertilization\/intracytoplasmic sperm injection","volume":"27","author":"Bergh","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2025.105206_bib0008","unstructured":"Chaimani, A., Caldwell, D., Li, T., Higgins, J., Salanti, G., 2022. Chapter 11: Undertaking network meta-analyses, in: Higgins, J., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M., Welch, V. (Eds.), Cochrane Handbook for Systematic Reviews of Interventions version 6.3, Cochrane. https:\/\/training.cochrane.org\/handbook"},{"issue":"5","key":"10.1016\/j.rbmo.2025.105206_bib0009","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jsbmb.2005.08.012","article-title":"Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study","volume":"97","author":"Chakravarty","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.rbmo.2025.105206_bib0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejogrb.2019.04.012","article-title":"Vaginal progesterone gel is non-inferior to intramuscular progesterone in efficacy with acceptable tolerability for luteal phase support: A prospective, randomized, multicenter study in China","volume":"237","author":"Chi","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1016\/j.rbmo.2025.105206_bib0011","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1472-6483(10)60597-4","article-title":"Vaginal gel versus intramuscular progesterone for luteal phase supplementation: a prospective randomized trial","volume":"16","author":"Dal Prato","year":"2008","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"10.1016\/j.rbmo.2025.105206_bib0012","article-title":"Progestogens for preventing miscarriage: a network meta-analysis","volume":"4","author":"Devall","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"7-8","key":"10.1016\/j.rbmo.2025.105206_bib0013","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.rbmo.2025.105206_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151388","article-title":"Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials","volume":"11","author":"Doblinger","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.rbmo.2025.105206_bib0015","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.fertnstert.2008.01.069","article-title":"Endometrin for luteal phase support in a randomized, controlled, open-label, prospective in-vitro fertilization trial using a combination of Menopur and Bravelle for controlled ovarian hyperstimulation","volume":"91","author":"Doody","year":"2009","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.rbmo.2025.105206_bib0016","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.fertnstert.2011.01.148","article-title":"Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in vitro fertilization: a randomized clinical study","volume":"95","author":"Ganesh","year":"2011","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.rbmo.2025.105206_bib0017","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1472-6483(10)60782-1","article-title":"Comparison between two forms of vaginally administered progesterone for luteal phase support in assisted reproduction cycles","volume":"14","author":"Geber","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.rbmo.2025.105206_bib0018","doi-asserted-by":"crossref","unstructured":"Greenbaum, S., Athavale, A., Hershko Klement, A., Bentov, Y., 2022. Luteal phase support in fresh and frozen embryo transfers. Front Reprod Health. 4, 919948. https:\/\/doi.org\/10.3389\/frph.2022.919948","DOI":"10.3389\/frph.2022.919948"},{"issue":"11","key":"10.1016\/j.rbmo.2025.105206_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241044","article-title":"Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis","volume":"15","author":"Griesinger","year":"2020","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.rbmo.2025.105206_bib0020","first-page":"2212","article-title":"Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial","volume":"33","author":"Griesinger","year":"2018","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.rbmo.2025.105206_bib0022","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.fertnstert.2013.06.034","article-title":"Progesterone luteal support after ovulation induction and intrauterine insemination: a systematic review and meta-analysis","volume":"100","author":"Hill","year":"2013","journal-title":"Fertil Steril"},{"issue":"11","key":"10.1016\/j.rbmo.2025.105206_bib0023","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.rbmo.2025.105206_bib0024","first-page":"745","article-title":"Addition of intramuscular to vaginal progesterone for luteal phase support in fresh embryo transfer cycles: A cross-sectional study","volume":"20","author":"Jalaliani","year":"2022","journal-title":"Int J Reprod Biomed"},{"issue":"6","key":"10.1016\/j.rbmo.2025.105206_bib0025","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/pst.533","article-title":"Statistical approaches for conducting network meta-analysis in drug development","volume":"10","author":"Jones","year":"2011","journal-title":"Pharm Stat"},{"issue":"5","key":"10.1016\/j.rbmo.2025.105206_bib0026","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.tjog.2021.10.010","article-title":"Clinical use of aqueous subcutaneous progesterone compared with vaginal progesterone as luteal support in in vitro fertilization: A randomized controlled study in Taiwan","volume":"61","author":"Kao","year":"2022","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.rbmo.2025.105206_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-64804-z","article-title":"Comparison of luteal support protocols in fresh IVF\/ICSI cycles: a network meta-analysis","volume":"14","author":"Kastora","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.rbmo.2025.105206_bib0028","doi-asserted-by":"crossref","first-page":"hoae004","DOI":"10.1093\/hropen\/hoae004","article-title":"No additional risk of congenital anomalies after first-trimester dydrogesterone use: a systematic review and meta-analysis","volume":"2024","author":"Katalinic","year":"2024","journal-title":"Hum Reprod Open"},{"issue":"2","key":"10.1016\/j.rbmo.2025.105206_bib0029","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.rbmo.2022.03.032","article-title":"A critical appraisal of safety data on dydrogesterone for the support of early pregnancy: a scoping review and meta-analysis","volume":"45","author":"Katalinic","year":"2022","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"10.1016\/j.rbmo.2025.105206_bib0030","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.fertnstert.2004.11.073","article-title":"Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction","volume":"83","author":"Kleinstein","year":"2005","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.rbmo.2025.105206_bib0031","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/oxfordjournals.humrep.a137087","article-title":"A prospective randomized trial of human chorionic gonadotrophin or dydrogesterone support following in-vitro fertilization and embryo transfer","volume":"5","author":"Kupferminc","year":"1990","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.rbmo.2025.105206_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2013.09.010","article-title":"Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study","volume":"101","author":"Lockwood","year":"2014","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.rbmo.2025.105206_bib0033","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0301-2115(02)00010-6","article-title":"Luteal phase support using either Crinone 8% or Utrogest: results of a prospective, randomized study","volume":"103","author":"Ludwig","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1016\/j.rbmo.2025.105206_bib0034","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.fertnstert.2004.11.003","article-title":"How do infertile couples choose their IVF centers? An Internet-based survey","volume":"83","author":"Marcus","year":"2005","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.rbmo.2025.105206_bib0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.36129\/jog.32.02.04","article-title":"In vitro fertilization and psychological stress: new insight about different routes of progesterone administration","volume":"32","author":"Mele","year":"2020","journal-title":"Ital J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.rbmo.2025.105206_bib0036","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ogc.2014.10.003","article-title":"Progesterone and the luteal phase: a requisite to reproduction","volume":"42","author":"Mesen","year":"2015","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"1","key":"10.1016\/j.rbmo.2025.105206_bib0037","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5507\/bp.2017.007","article-title":"Vaginal use of micronized progesterone for luteal support.A randomized study comparing Utrogestan\u00ae and Crinone\u00ae 8","volume":"161","author":"Michnova","year":"2017","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"issue":"3","key":"10.1016\/j.rbmo.2025.105206_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2019.04.021","article-title":"Evaluation of progestogen supplementation for luteal phase support in fresh in vitro fertilization cycles","volume":"112","author":"Mohammed","year":"2019","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.rbmo.2025.105206_bib0039","doi-asserted-by":"crossref","first-page":"112","DOI":"10.5114\/aoms.2011.20613","article-title":"The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles - a randomized controlled study","volume":"7","author":"Moini","year":"2011","journal-title":"Arch Med Sci"},{"issue":"1","key":"10.1016\/j.rbmo.2025.105206_bib0040","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41073-023-00130-8","article-title":"Checklist to assess Trustworthiness in RAndomised Controlled Trials (TRACT checklist): concept proposal and pilot","volume":"8","author":"Mol","year":"2023","journal-title":"Res Integr Peer Rev"},{"issue":"2","key":"10.1016\/j.rbmo.2025.105206_bib0041","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jrsm.1463","article-title":"Network meta-analysis results against a fictional treatment of average performance: Treatment effects and ranking metric","volume":"12","author":"Nikolakopoulou","year":"2021","journal-title":"Res Synth Methods"},{"issue":"10","key":"10.1016\/j.rbmo.2025.105206_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2020.101838","article-title":"Luteal phase support in fresh and frozen embryo transfer cycles","volume":"49","author":"Pabu\u00e7cu","year":"2020","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"Suppl 1","key":"10.1016\/j.rbmo.2025.105206_bib0043","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/09513590701584857","article-title":"Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone","volume":"23","author":"Patki","year":"2007","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"10.1016\/j.rbmo.2025.105206_bib0044","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0015-0282(01)02872-2","article-title":"A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles","volume":"76","author":"Propst","year":"2001","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.rbmo.2025.105206_bib0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11739-016-1583-7","article-title":"Network meta-analysis: an introduction for clinicians","volume":"12","author":"Rouse","year":"2017","journal-title":"Intern Emerg Med"},{"issue":"4","key":"10.1016\/j.rbmo.2025.105206_bib0046","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jrsm.1058","article-title":"Network meta-analysis, electrical networks and graph theory","volume":"3","author":"R\u00fccker","year":"2012","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.rbmo.2025.105206_bib0047","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"10.1016\/j.rbmo.2025.105206_bib0048","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/09513590.2015.1110136","article-title":"A comparative study of dydrogesterone and micronized progesterone for luteal phase support during in vitro fertilization (IVF) cycles","volume":"32","author":"Saharkhiz","year":"2016","journal-title":"Gynecol Endocrinol"},{"issue":"11","key":"10.1016\/j.rbmo.2025.105206_bib0049","first-page":"913","article-title":"Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): A randomized clinical trial","volume":"11","author":"Salehpour","year":"2013","journal-title":"Iran J Reprod Med"},{"issue":"2","key":"10.1016\/j.rbmo.2025.105206_bib0050","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/humrep\/dez261","article-title":"Efficacy, safety and tolerability of progesterone vaginal pessaries versus progesterone vaginal gel for luteal phase support after in vitro fertilisation: a randomised controlled trial","volume":"35","author":"Saunders","year":"2020","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.rbmo.2025.105206_bib0052","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.fertnstert.2006.05.067","article-title":"Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support","volume":"87","author":"Simunic","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2025.105206_bib0053","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"Bmj"},{"issue":"4","key":"10.1016\/j.rbmo.2025.105206_bib0054","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/humrep\/dez017","article-title":"Are interventions in reproductive medicine assessed for plausible and clinically relevant effects? A systematic review of power and precision in trials and meta-analyses","volume":"34","author":"Stocking","year":"2019","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.rbmo.2025.105206_bib0055","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.rbmo.2022.04.019","article-title":"Does the HCG trigger dose used for IVF impact luteal progesterone concentrations? a randomized controlled trial","volume":"45","author":"Svenstrup","year":"2022","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"10.1016\/j.rbmo.2025.105206_bib0056","first-page":"455","article-title":"Dydrogest\u00e9rone vs progest\u00e9rone vaginale micronis\u00e9e dans le soutien de la phase lut\u00e9ale apr\u00e8s transfert frais d\u2019embryons [Dydrogesterone versus micronized vaginal progesterone as luteal phase support after fresh embryo transfer in IVF]","volume":"50","author":"Tataru","year":"2022","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"2","key":"10.1016\/j.rbmo.2025.105206_bib0057","first-page":"151","article-title":"The impact of luteal supplement on pregnancy outcome following stimulated IVF cycles","volume":"60","author":"Tay","year":"2005","journal-title":"Med J Malaysia"},{"issue":"2","key":"10.1016\/j.rbmo.2025.105206_bib0058","doi-asserted-by":"crossref","first-page":"hoaa009","DOI":"10.1093\/hropen\/hoaa009","article-title":"ESHRE guideline: ovarian stimulation for IVF\/ICSI(\u2020)","volume":"2020","author":"Bosch","year":"2020","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.rbmo.2025.105206_bib0059","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejogrb.2014.11.002","article-title":"Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial","volume":"186","author":"Tomic","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.rbmo.2025.105206_bib0060","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/humrep\/dex023","article-title":"A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization","volume":"32","author":"Tournaye","year":"2017","journal-title":"Hum Reprod"},{"issue":"7","key":"10.1016\/j.rbmo.2025.105206_bib0061","article-title":"Luteal phase support for assisted reproduction cycles","volume":"2015","author":"van der Linden","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.rbmo.2025.105206_bib0062","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/humrep\/dez235","article-title":"The early luteal hormonal profile in IVF patients triggered with hCG","volume":"35","author":"Vuong","year":"2020","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.rbmo.2025.105206_bib0063","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1071\/RD9900351","article-title":"Salivary oestradiol and progesterone after in vitro fertilization and embryo transfer using different luteal support regimens","volume":"2","author":"Wong","year":"1990","journal-title":"Reprod Fertil Dev"},{"issue":"7","key":"10.1016\/j.rbmo.2025.105206_bib0064","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1016\/j.fertnstert.2010.02.033","article-title":"Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study","volume":"94","author":"Yanushpolsky","year":"2010","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.rbmo.2025.105206_bib0065","first-page":"229","article-title":"Comparison the Effectiveness of Oral Dydrogesterone, Vaginal Progesterone Suppository and Progesterone Ampule for Luteal Phase Support on Pregnancy Rate during ART Cycles","volume":"5","author":"Zargar","year":"2016","journal-title":"Int J Pharm Res Allied Sci"}],"updated-by":[{"DOI":"10.1016\/j.rbmo.2026.105870","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000}}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648325004134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648325004134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T19:59:14Z","timestamp":1785009554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648325004134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1472648325004134"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2025.105206","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Network meta-analysis of progestogen administration routes for luteal phase support in fresh embryo transfer IVF cycles","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2025.105206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of Reproductive Healthcare Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105206"}}